IFF Sells Botanical Extracts and Food Enhancement Businesses for $170M
Event summary
- IFF agreed to sell its botanical extracts, vitamins & minerals, and food enhancement activities to SuanNutra for approximately $170M in 2025 revenue.
- The deal includes five manufacturing facilities across Europe, the U.S., and Latin America, employing about 600 people.
- Transaction expected to close by the end of 2026, subject to regulatory approvals.
- IFF positions the sale as part of its focus on core businesses: Taste, Scent, and Health & Biosciences.
The big picture
IFF’s sale reflects a broader trend among conglomerates to streamline operations and focus on higher-margin, innovation-driven segments. The $170M revenue divestiture underscores the strategic shift toward Taste, Scent, and Health & Biosciences, where IFF sees greater potential for sustainable growth. Carbyne Equity Partners’ involvement highlights private equity’s appetite for specialized ingredient businesses.
What we're watching
- Portfolio Focus
- How IFF’s divestiture will impact its ability to drive long-term growth in core segments.
- Integration Risk
- Whether SuanNutra can successfully integrate the acquired operations and maintain revenue momentum.
- Regulatory Hurdles
- The pace at which regulatory approvals will be secured, given the cross-border nature of the deal.
Related topics